ANTITUMOR NECROSIS FACTOR-ALPHA PREVENTS DECREASED VENTRICULAR CONTRACTILITY IN ENDOTOXEMIC PIGS

被引:59
作者
HERBERTSON, MJ
WERNER, HA
GODDARD, CM
RUSSELL, JA
WHEELER, A
COXON, R
WALLEY, KR
机构
[1] UNIV BRITISH COLUMBIA,ST PAULS HOSP,PULM RES LAB,VANCOUVER,BC V6Z 1Y6,CANADA
[2] VANDERBILT UNIV,DIV PULM & CRIT CARE MED,NASHVILLE,TN 37240
[3] ST BARTHOLOMEWS HOSP,DEPT CHEM PATHOL,LONDON,ENGLAND
关键词
D O I
10.1164/ajrccm.152.2.7633696
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
It is not known how the decrease in left ventricular contractility following endotoxin exposure is mediated, or whether this decrease is preventable by antibodies to tumor necrosis factor-alpha (TNF alpha). Four groups of six anesthetized and instrumented pigs were pretreated with ovine polyclonal antibody to human TNF alpha (anti-TNF alpha), nonspecific IgG, or saline, and then treated with either endotoxin or saline. We measured hemodynamics and left ventricular pressures (Millar catheter) and volumes (conductance catheter). Left ventricular contractility was assessed using the slope (E(max)) of the end-systolic pressure-volume relationship. Four hours after the start of endotoxin infusion In the nonspecific IgG pretreated group, E(max) had decreased by 44 +/- 6% (p < 0.05), mean arterial pressure had decreased from 115 +/- 7 mm Hg to 70 +/- 10 mm Hg (p < 0.05), and cardiac output was rapidly decreasing after an initial increase (p < 0.05). Anti-TNF alpha significantly reduced the decrease in E(max) (11 +/- 9%, p < 0.05), and the systemic hypotension (108 +/- 15 mm Hg to 99 +/- 6 mm Hg, p < 0.05), at 4 h, and prevented the late decrease in cardiac output. This suggests that TNF alpha is an important early mediator in sepsis leading to decreased left ventricular contractility.
引用
收藏
页码:480 / 488
页数:9
相关论文
共 37 条
[1]   SIMULTANEOUS CONDUCTANCE CATHETER AND DIMENSION ASSESSMENT OF LEFT-VENTRICLE VOLUME IN THE INTACT ANIMAL [J].
APPLEGATE, RJ ;
CHENG, CP ;
LITTLE, WC .
CIRCULATION, 1990, 81 (02) :638-648
[2]   CONTINUOUS MEASUREMENT OF LEFT-VENTRICULAR VOLUME IN ANIMALS AND HUMANS BY CONDUCTANCE CATHETER [J].
BAAN, J ;
VANDERVELDE, ET ;
DEBRUIN, HG ;
SMEENK, GJ ;
KOOPS, J ;
VANDIJK, AD ;
TEMMERMAN, D ;
SENDEN, J ;
BUIS, B .
CIRCULATION, 1984, 70 (05) :812-823
[3]   DIVERGENT EFFICACY OF ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA IN INTRAVASCULAR AND PERITONITIS MODELS OF SEPSIS [J].
BAGBY, GJ ;
PLESSALA, KJ ;
WILSON, LA ;
THOMPSON, JJ ;
NELSON, S .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (01) :83-88
[4]   NITRIC-OXIDE PRODUCTION WITHIN CARDIAC MYOCYTES REDUCES THEIR CONTRACTILITY IN ENDOTOXEMIA [J].
BRADY, AJB ;
POOLEWILSON, PA ;
HARDING, SE ;
WARREN, JB .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (06) :H1963-H1966
[5]  
CHENSUE SW, 1991, AM J PATHOL, V138, P395
[6]   REVERSIBLE CARDIAC DYSFUNCTION ASSOCIATED WITH INTERFERON ALFA THERAPY IN AIDS PATIENTS WITH KAPOSIS SARCOMA [J].
DEYTON, LR ;
WALKER, RE ;
KOVACS, JA ;
HERPIN, B ;
PARKER, M ;
MASUR, H ;
FAUCI, AS ;
LANE, HC .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (18) :1246-1249
[7]  
ECHTENACHER B, 1990, J IMMUNOL, V145, P3762
[8]   TUMOR-NECROSIS-FACTOR CHALLENGES IN CANINES - PATTERNS OF CARDIOVASCULAR DYSFUNCTION [J].
EICHENHOLZ, PW ;
EICHACKER, PQ ;
HOFFMAN, WD ;
BANKS, SM ;
PARRILLO, JE ;
DANNER, RL ;
NATANSON, C .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (03) :H668-H675
[9]  
FIEDLER VB, 1992, J LAB CLIN MED, V120, P574
[10]   INFLUENCE OF AN ANTITUMOR NECROSIS FACTOR MONOCLONAL-ANTIBODY ON CYTOKINE LEVELS IN PATIENTS WITH SEPSIS [J].
FISHER, CJ ;
OPAL, SM ;
DHAINAUT, JF ;
STEPHENS, S ;
ZIMMERMAN, JL ;
NIGHTINGALE, P ;
HARRIS, SJ ;
SCHEIN, RMH ;
PANACEK, EA ;
VINCENT, JL ;
FOULKE, GE ;
WARREN, EL ;
GARRARD, C ;
PARK, G ;
BODMER, MW ;
COHEN, J ;
VANDERLINDEN, C ;
CROSS, AS ;
SADOFF, JC ;
GORECKI, J ;
DUBIN, HG ;
GARNER, C ;
KAYE, W ;
LANORE, JJ ;
MIRA, JP ;
ZIMMERMAN, J ;
DELLINGER, RP ;
TAYLOR, RW ;
DAHL, S ;
SHELLY, M ;
MORTIMER, A ;
EDWARDS, JD ;
KETT, DH ;
QUARTIN, A ;
PENA, MA ;
BAKKER, J ;
ALBERSON, TE ;
WALBY, W ;
RADCLIFFE, J ;
YOUNG, D ;
MCQUILLAM, P ;
BELLINGHAM, G ;
BURMAN, W ;
SADOFF, JS ;
YOUNG, L .
CRITICAL CARE MEDICINE, 1993, 21 (03) :318-327